Semler Scientific reached an agreement in principle with the U.S. Department of Justice to settle fraud claims for $29.75 million.
The settlement relates to a civil investigational demand issued by the Justice Department concerning alleged violations under the False Claims Act, according to a Form 8-K filed April 15.
While the deal is not finalized, Semler acknowledged that it may still need to secure agreement from HHS and undertake additional compliance obligations. If a final agreement cannot be reached, the department could still pursue litigation seeking damages exceeding the original proposed amount, according to the Form 8-K.
The company also reported a preliminary operating loss of up to $1.5 million for the first quarter of 2025 including $400,000 in legal costs tied to the DOJ investigation.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
